Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Other Operating Expenses (2020)

Historic Other Operating Expenses for Cogent Biosciences (COGT) over the last 1 years, with Q3 2020 value amounting to $46.9 million.

  • Cogent Biosciences' Other Operating Expenses changed N/A to $46.9 million in Q3 2020 from the same period last year, while for Jun 2021 it was $46.9 million, marking a year-over-year change of. This contributed to the annual value of $46.9 million for FY2020, which is N/A changed from last year.
  • Latest data reveals that Cogent Biosciences reported Other Operating Expenses of $46.9 million as of Q3 2020.
  • Over the past 5 years, Cogent Biosciences' Other Operating Expenses peaked at $46.9 million during Q3 2020, and registered a low of $46.9 million during Q3 2020.